GDF15 suppresses liver inflammation independently of weight loss through neuroendocrine glucocorticoid signaling
Authors:
Open Access
- 10 August 2026
- journal article
- Published by Elsevier in Cell Metabolism
- Vol. 38 (10) , 2128-2142.e6
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (201709FDN-CEBA-116200)
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2026-07553)
- Natural Sciences and Engineering Research Council of Canada (DGECR-2026-00438)
This publication has 82 references indexed in Scilit:
- GDF15 Neutralization Ameliorates Muscle Atrophy and Exercise Intolerance in a Mouse Model of Mitochondrial MyopathyJournal of Cachexia, Sarcopenia and Muscle, 2025
- GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanismCell Metabolism, 2023
- Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASHCell Reports, 2022
- Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemiaCell Metabolism, 2022
- Metabolic modeling of single Th17 cells reveals regulators of autoimmunityCell, 2021
- The Emerging Role of B Cells in the Pathogenesis of NAFLDHepatology, 2021
- Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3Hepatology, 2019
- GDF15 Is an Inflammation-Induced Central Mediator of Tissue ToleranceCell, 2019
- Adipose Tissue Macrophages Promote Myelopoiesis and Monocytosis in ObesityCell Metabolism, 2014
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005